4-Benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester, 95.0%, 5g

2-(tert-Butyl) 8-methyl 5-thia-2-azaspiro[3.4]octane-2,8-dicarboxylate, 97%, 5g

ETHYL 2-((5,6-DICHLORO-2-CYANOPYRIDIN-3-YL)OXY)ACETATE, 95.0%, 500mg

1-methylazetidin-3-one hydrochloride, 95.0%, 1g

Lithium 9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoate, 95%, 1g

5-(3-Bromo-4-fluorophenyl)pentanoic acid, 95%, 5g

2-[Bis(tert-Butoxycarbonyl)amino]-5-bromopyrimidine, 95.0%, 100g

Ectoine>98.0%(HPLC)(T)1g

2-Chloro-5-methylanisole, 95.0%, 2g

Pitavastatin Calcium (contains 15% Water at maximum)>98.0%(HPLC)(T)250mg

Dispensadores Dispensette® S Análogo orgánico con válvula de retorno, 2,5–25 ml, 1 pieza

4-Pyrrolidin-1-yl-phenylamine, 95.0%, 1g

3,5-Dimethoxyphenylacetic acid, 98.0%, 100g